Key result
Visceral adipose tissue in colorectal cancer patients showed elevated expression of inflammatory and metabolic genes compared to subcutaneous tissue, with visceral fat area poorly correlating with BMI.
Why the study?
Distinct adipose tissue depots strongly differ metabolically, but comprehensive studies of depot-specific perturbations among patients with cancer are lacking.
Observational (n=233)
BMI poorly correlates with fat mass-associated changes in visceral adipose tissue, highlighting the need to differentiate between distinct adipose tissue depots to accurately characterize metabolic health in colorectal cancer patients.
BMI may misclassify metabolic risk in colorectal cancer; leaves open whether visceral adipose profiling refines stratification or outcomes.
CONTEXT: Adipose tissue inflammation and dysregulated energy homeostasis are key mechanisms linking obesity and cancer. Distinct adipose tissue depots strongly differ in their metabolic profiles; however, comprehensive studies of depot-specific perturbations among patients with cancer are lacking. OBJECTIVE: We compared transcriptome profiles of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) from patients with colorectal cancer and assessed the associations of different anthropometric measures with depot-specific gene expression. DESIGN: Whole transcriptomes of VAT and SAT were measured in 233 patients from the ColoCare Study, and visceral and subcutaneous fat area were quantified via CT. RESULTS: VAT compared with SAT showed elevated gene expression of cytokines, cell adhesion molecules, and key regulators of metabolic homeostasis. Increased fat area was associated with downregulated lipid and small molecule metabolism and upregulated inflammatory pathways in both compartments. Comparing these patterns between depots proved specific and more pronounced gene expression alterations in SAT and identified unique associations of integrins and lipid metabolism-related enzymes. VAT gene expression patterns that were associated with visceral fat area poorly overlapped with patterns associated with self-reported body mass index (BMI). However, subcutaneous fat area and BMI showed similar associations with SAT gene expression. CONCLUSIONS: This large-scale human study demonstrates pronounced disparities between distinct adipose tissue depots and reveals that BMI poorly correlates with fat mass-associated changes in VAT. Taken together, these results provide crucial evidence for the necessity to differentiate between distinct adipose tissue depots for a correct characterization of gene expression profiles that may affect metabolic health of patients with colorectal cancer.
No takes yet. Share an insight, caveat, or question.
Haffa et al. (2019) conducted an observational in Colorectal cancer (n=233). Visceral adipose tissue (VAT) vs. Subcutaneous adipose tissue (SAT) was evaluated on Depot-specific gene expression alterations. Visceral adipose tissue in colorectal cancer patients showed elevated expression of inflammatory and metabolic genes compared to subcutaneous tissue, with visceral fat area poorly correlating with BMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: